BEAMNasdaq

Beam Therapeutics Inc.

Alert me on BEAM

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Oct 4, 2025 Sale Evans John M. Insider

1 week

−1.9%S&P −1.3%

1 month

−12.2%S&P +0.5%

3 months

+9.5%S&P +3.3%

6 months

−1.7%S&P +1.2%

Oct 4, 2025 Sale Bellon Christine Insider

1 week

−1.9%S&P −1.3%

1 month

−12.2%S&P +0.5%

3 months

+9.5%S&P +3.3%

6 months

−1.7%S&P +1.2%

Oct 4, 2025 Sale Cavanagh Bethany J Insider

1 week

−1.9%S&P −1.3%

1 month

−12.2%S&P +0.5%

3 months

+9.5%S&P +3.3%

6 months

−1.7%S&P +1.2%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for BEAM 7 held · newest first

Loading the filings.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

$51KQ3 2025

$51KQ4 2025

NoneQ1 2026

$10KQ2 2026

Down 80 percent from Q4 2025. Reported to the Senate each quarter by the firms it hires.Original report ↗

Read from LDA.gov on Sep 23, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.